Medicus Pharma Ltd. Common Stock (MDCX) is a publicly traded Healthcare sector company. As of September 3, 2026, MDCX trades at $0.18 with a market cap of $15.87M and a P/E ratio of -0.10. MDCX moved -29.47% today. Year to date, MDCX is -83.76%; over the trailing twelve months it is -86.94%. Its 52-week range spans $0.24 to $8.94. Analyst consensus is strong buy with an average price target of $3.97. Rallies surfaces MDCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MDCX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.18 |
| Market Cap | $15.87M |
| P/E Ratio | -0.10 |
| EPS | $-2.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.94 |
| 52-Week Low | $0.24 |
| Volume | 80.74M |
| Avg Volume | 0 |
| Revenue (TTM) | $-261.25K |
| Net Income | $-44.89M |
| Gross Margin | 0.00% |
3 analysts cover MDCX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.97.